Nektar Therapeutics Increase (Decrease) in Accounts Payable
Nektar Therapeutics (NKTR) reported Increase (Decrease) in Accounts Payable of $14.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14
- Nektar Therapeutics increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $15.05M.
- Nektar Therapeutics increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$934.00K, a 114.57% decline year-over-year.
- Nektar Therapeutics increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$4.79M, a 229.86% decline year-over-year.
- Nektar Therapeutics increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.28M, a 42.84% decline year-over-year.
- Nektar Therapeutics increase (decrease) in accounts payable for fiscal 2025 was -$625.00K, a 123.43% decline from fiscal 2024.
- Nektar Therapeutics increase (decrease) in accounts payable for fiscal 2024 was $2.67M.
- Nektar Therapeutics increase (decrease) in accounts payable for fiscal 2023 was -$2.88M, a 192.94% decline from fiscal 2022.
- Nektar Therapeutics increase (decrease) in accounts payable for fiscal 2022 was $3.10M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $14.12M 10-Q · filed 2026-08-14 | $9.33M derived: sum of 3 quarters · filed 2026-08-14 | $10.61M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$934.00K 10-Q · filed 2026-05-08 | -$5.73M derived: sum of 2 quarters · filed 2026-05-08 | -$4.45M derived: sum of 3 quarters · filed 2026-05-08 | -$7.97M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$3.51M derived: sum of 2 quarters · filed 2026-03-13 | -$7.04M derived: sum of 3 quarters · filed 2026-08-14 | -$625.00K 10-K · filed 2026-03-13 |
| 2025-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$2.24M derived: sum of 2 quarters · filed 2026-08-14 | $4.17M 10-Q · filed 2025-11-07 | $7.86M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.89M 10-Q · filed 2026-08-14 | $6.58M derived: sum of 3 quarters · filed 2026-08-14 | $8.82M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $6.41M 10-Q · filed 2026-05-08 | $10.10M derived: sum of 2 quarters · filed 2026-05-08 | $12.34M derived: sum of 3 quarters · filed 2026-05-08 | $10.07M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $5.93M derived: sum of 2 quarters · filed 2026-03-13 | $3.66M derived: sum of 3 quarters · filed 2026-03-13 | $2.67M 10-K · filed 2026-03-13 |
| 2024-09-30 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$35.00K derived: sum of 2 quarters · filed 2025-11-07 | -$1.02M 10-Q · filed 2025-11-07 | $5.42M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$3.27M 10-Q · filed 2025-08-08 | $3.18M derived: sum of 3 quarters · filed 2025-08-08 | $3.85M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$988.00K 10-Q · filed 2025-05-09 | $5.46M derived: sum of 2 quarters · filed 2025-05-09 | $6.13M derived: sum of 3 quarters · filed 2025-05-09 | $5.05M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $7.11M derived: sum of 2 quarters · filed 2025-03-14 | $6.04M derived: sum of 3 quarters · filed 2025-03-14 | -$2.88M 10-K · filed 2025-03-14 |
| 2023-09-30 | $669.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$408.00K derived: sum of 2 quarters · filed 2024-11-08 | -$9.33M 10-Q · filed 2024-11-08 | -$2.04M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$10.00M 10-Q · filed 2024-08-09 | -$2.71M derived: sum of 3 quarters · filed 2024-08-09 | -$9.73M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$8.92M 10-Q · filed 2024-05-10 | -$1.63M derived: sum of 2 quarters · filed 2024-05-10 | -$8.65M derived: sum of 3 quarters · filed 2024-05-10 | -$8.81M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $7.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $270.00K derived: sum of 2 quarters · filed 2024-03-05 | $105.00K derived: sum of 3 quarters · filed 2024-03-05 | $3.10M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$7.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$7.18M derived: sum of 2 quarters · filed 2023-11-08 | -$4.18M 10-Q · filed 2023-11-08 | -$17.12M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | -$165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.83M 10-Q · filed 2023-08-09 | -$10.10M derived: sum of 3 quarters · filed 2024-03-05 | -$6.76M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $3.00M 10-Q · filed 2023-05-10 | -$9.94M derived: sum of 2 quarters · filed 2024-03-05 | -$6.59M derived: sum of 3 quarters · filed 2024-03-05 | -$9.47M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$12.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$9.59M derived: sum of 2 quarters · filed 2024-03-05 | -$12.47M derived: sum of 3 quarters · filed 2024-03-05 | -$11.69M 10-K · filed 2024-03-05 |
| 2021-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $468.00K derived: sum of 2 quarters · filed 2022-11-04 | $1.25M 10-Q · filed 2022-11-04 | $6.97M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$2.10M 10-Q · filed 2022-08-05 | $3.62M derived: sum of 3 quarters · filed 2023-02-28 | -$144.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $779.00K 10-Q · filed 2022-05-06 | $6.50M derived: sum of 2 quarters · filed 2023-02-28 | $2.74M derived: sum of 3 quarters · filed 2023-02-28 | $474.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.96M derived: sum of 2 quarters · filed 2023-02-28 | -$305.00K derived: sum of 3 quarters · filed 2023-02-28 | $2.38M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$3.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$6.02M derived: sum of 2 quarters · filed 2021-11-05 | -$3.34M 10-Q · filed 2021-11-05 | -$6.48M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $425.00K 10-Q · filed 2021-08-06 | -$2.72M derived: sum of 3 quarters · filed 2022-03-01 | $9.91M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.69M 10-Q · filed 2021-05-07 | -$455.00K derived: sum of 2 quarters · filed 2022-03-01 | $12.17M derived: sum of 3 quarters · filed 2022-03-01 | $10.50M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $9.49M derived: sum of 2 quarters · filed 2022-03-01 | $7.81M derived: sum of 3 quarters · filed 2022-03-01 | $12.97M 10-K · filed 2022-03-01 |
| 2019-09-30 | $12.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $10.95M derived: sum of 2 quarters · filed 2020-11-06 | $16.11M 10-Q · filed 2020-11-06 | $14.47M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.48M 10-Q · filed 2020-08-07 | $1.84M derived: sum of 3 quarters · filed 2021-02-26 | -$1.34M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $5.16M 10-Q · filed 2020-05-08 | $3.52M derived: sum of 2 quarters · filed 2021-02-26 | $336.00K derived: sum of 3 quarters · filed 2021-02-26 | -$365.00K derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$4.82M derived: sum of 2 quarters · filed 2021-02-26 | -$5.52M derived: sum of 3 quarters · filed 2021-02-26 | $971.00K 10-K · filed 2021-02-26 |
| 2018-09-30 | -$3.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$3.88M derived: sum of 2 quarters · filed 2019-11-07 | $2.61M 10-Q · filed 2019-11-07 | -$1.04M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $5.79M 10-Q · filed 2019-08-09 | $2.14M derived: sum of 3 quarters · filed 2020-02-28 | $4.64M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $6.49M 10-Q · filed 2019-05-09 | $2.84M derived: sum of 2 quarters · filed 2020-02-28 | $5.34M derived: sum of 3 quarters · filed 2020-02-28 | $4.45M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$1.15M derived: sum of 2 quarters · filed 2020-02-28 | -$2.04M derived: sum of 3 quarters · filed 2020-02-28 | $2.07M 10-K · filed 2020-02-28 |
| 2017-09-30 | $2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.61M derived: sum of 2 quarters · filed 2018-11-08 | $5.73M 10-Q · filed 2018-11-08 | $1.45M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$896.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $3.22M 10-Q · filed 2018-08-09 | -$1.06M derived: sum of 3 quarters · filed 2019-03-01 | $3.72M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $4.12M 10-Q · filed 2018-05-10 | -$164.00K derived: sum of 2 quarters · filed 2019-03-01 | $4.62M derived: sum of 3 quarters · filed 2019-03-01 | $4.67M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $501.00K derived: sum of 2 quarters · filed 2019-03-01 | $552.00K derived: sum of 3 quarters · filed 2019-03-01 | $518.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | $4.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $4.83M derived: sum of 2 quarters · filed 2017-11-08 | $4.80M 10-Q · filed 2017-11-08 | $4.91M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $17.00K 10-Q · filed 2017-08-09 | $130.00K derived: sum of 3 quarters · filed 2018-03-01 | -$385.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$34.00K 10-Q · filed 2017-05-10 | $79.00K derived: sum of 2 quarters · filed 2018-03-01 | -$436.00K derived: sum of 3 quarters · filed 2018-03-01 | -$2.69M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$402.00K derived: sum of 2 quarters · filed 2018-03-01 | -$2.65M derived: sum of 3 quarters · filed 2018-03-01 | -$412.00K 10-K · filed 2018-03-01 |
| 2015-09-30 | -$515.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$2.77M derived: sum of 2 quarters · filed 2016-11-04 | -$525.00K 10-Q · filed 2016-11-04 | -$3.21M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$10.00K 10-Q · filed 2016-08-04 | -$2.70M derived: sum of 3 quarters · filed 2017-03-01 | -$4.55M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $2.24M 10-Q · filed 2016-05-04 | -$448.00K derived: sum of 2 quarters · filed 2017-03-01 | -$2.30M derived: sum of 3 quarters · filed 2017-03-01 | $2.01M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$4.54M derived: sum of 2 quarters · filed 2017-03-01 | -$233.00K derived: sum of 3 quarters · filed 2017-03-01 | -$6.36M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $2.46M derived: sum of 2 quarters · filed 2015-11-06 | -$3.67M 10-Q · filed 2015-11-06 | $1.83M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$1.82M 10-Q · filed 2015-08-06 | $3.68M derived: sum of 3 quarters · filed 2016-02-29 | $1.75M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$6.13M 10-Q · filed 2015-05-01 | -$624.00K derived: sum of 2 quarters · filed 2016-02-29 | -$2.56M derived: sum of 3 quarters · filed 2016-02-29 | -$1.28M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $3.57M derived: sum of 2 quarters · filed 2016-02-29 | $4.84M derived: sum of 3 quarters · filed 2016-02-29 | $6.20M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$658.00K derived: sum of 2 quarters · filed 2014-11-07 | $697.00K 10-Q · filed 2014-11-07 | $976.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $2.63M 10-Q · filed 2014-08-01 | $2.91M derived: sum of 3 quarters · filed 2015-02-26 | $2.43M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $1.35M 10-Q · filed 2014-05-08 | $1.63M derived: sum of 2 quarters · filed 2015-02-26 | $1.15M derived: sum of 3 quarters · filed 2015-02-26 | $2.52M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$202.00K derived: sum of 2 quarters · filed 2015-02-26 | $1.17M derived: sum of 3 quarters · filed 2015-02-26 | -$122.00K 10-K · filed 2015-02-26 |
| 2012-09-30 | -$481.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $889.00K derived: sum of 2 quarters · filed 2013-11-07 | -$401.00K 10-Q · filed 2013-11-07 | $415.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $80.00K 10-Q · filed 2013-08-09 | $896.00K derived: sum of 3 quarters · filed 2014-02-27 | -$155.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$1.29M 10-Q · filed 2013-05-09 | -$474.00K derived: sum of 2 quarters · filed 2014-02-27 | -$1.52M derived: sum of 3 quarters · filed 2014-02-27 | -$1.78M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $816.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$235.00K derived: sum of 2 quarters · filed 2014-02-27 | -$489.00K derived: sum of 3 quarters · filed 2014-02-27 | -$3.38M 10-K · filed 2014-02-27 |
| 2011-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$1.30M derived: sum of 2 quarters · filed 2012-11-09 | -$4.20M 10-Q · filed 2012-11-09 | -$1.68M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | -$254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$3.15M 10-Q · filed 2012-08-09 | -$630.00K derived: sum of 3 quarters · filed 2013-03-01 | -$1.06M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | -$2.90M 10-Q · filed 2012-05-04 | -$376.00K derived: sum of 2 quarters · filed 2013-03-01 | -$804.00K derived: sum of 3 quarters · filed 2013-03-01 | -$369.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $2.09M derived: sum of 2 quarters · filed 2013-03-01 | $2.53M derived: sum of 3 quarters · filed 2013-03-01 | $4.27M 10-K · filed 2013-03-01 |
| 2010-09-30 | -$428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $7.00K derived: sum of 2 quarters · filed 2011-11-04 | $1.75M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $435.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $2.18M 10-Q · filed 2011-08-05 | ||
| 2010-03-31 | $1.75M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | -$8.05M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |